Literature DB >> 9841844

Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996.

L L Han1, F Popovici, J P Alexander, V Laurentia, L A Tengelsen, C Cernescu, H E Gary, N Ion-Nedelcu, G L Campbell, T F Tsai.   

Abstract

In 1996, an epidemic of 393 cases of laboratory-confirmed West Nile meningoencephalitis occurred in southeast Romania, with widespread subclinical human infection. Two case-control studies were performed to identify risk factors for acquiring infection and for developing clinical meningoencephalitis after infection. Mosquitoes in the home were associated with infection (reported by 37 [97%] of 38 asymptomatically seropositive persons compared with 36 [72%] of 50 seronegative controls, P<.01) and, among apartment dwellers, flooded basements were a risk factor (reported by 15 [63%] of 24 seropositive persons vs. 11 [30%] of 37 seronegative controls, P=.01). Meningoencephalitis was not associated with hypertension or other underlying medical conditions but was associated with spending more time outdoors (meningoencephalitis patients and asymptomatically seropositive persons spent 8.0 and 3.5 h [medians] outdoors daily, respectively, P<.01). Disease prevention efforts should focus on eliminating peridomestic mosquito breeding sites and reducing peridomestic mosquito exposure.

Entities:  

Mesh:

Year:  1999        PMID: 9841844     DOI: 10.1086/314566

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  West Nile virus - where did it come from and where might it go?

Authors:  B L Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2000-07

3.  Human surveillance for West Nile virus infection in Ontario in 2000.

Authors:  E Lee Ford-Jones; Margaret Fearon; Chuck Leber; Prabo Dwight; Moira Myszak; Beverly Cole; Pam Baker Greene; Sheila Artes; Allison McGeer; Colin D'Cunha; Monika Naus
Journal:  CMAJ       Date:  2002-01-08       Impact factor: 8.262

4.  West Nile virus-associated acute flaccid paralysis.

Authors:  Ashely Alker
Journal:  BMJ Case Rep       Date:  2015-05-02

5.  Relating West Nile virus case fatality rates to demographic and surveillance variables.

Authors:  Julie Tackett; Richard Charnigo; Glyn Caldwell
Journal:  Public Health Rep       Date:  2006 Nov-Dec       Impact factor: 2.792

6.  Modifiable risk factors for West Nile virus infection during an outbreak--Arizona, 2010.

Authors:  Katherine B Gibney; James Colborn; Steven Baty; Andrean M Bunko Patterson; Tammy Sylvester; Graham Briggs; Tasha Stewart; Craig Levy; Ken Komatsu; Katherine MacMillan; Mark J Delorey; John-Paul Mutebi; Marc Fischer; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

7.  Medical risk factors for severe West Nile Virus disease, United States, 2008-2010.

Authors:  Nicole P Lindsey; J Erin Staples; Jennifer A Lehman; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

Review 8.  West Nile virus: a reemerging global pathogen.

Authors:  L R Petersen; J T Roehrig
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

9.  Local impact of temperature and precipitation on West Nile virus infection in Culex species mosquitoes in northeast Illinois, USA.

Authors:  Marilyn O Ruiz; Luis F Chaves; Gabriel L Hamer; Ting Sun; William M Brown; Edward D Walker; Linn Haramis; Tony L Goldberg; Uriel D Kitron
Journal:  Parasit Vectors       Date:  2010-03-19       Impact factor: 3.876

10.  Epidemiology of West Nile infection in Volgograd, Russia, in relation to climate change and mosquito (Diptera: Culicidae) bionomics.

Authors:  Alexander E Platonov; Marina V Fedorova; Ludmila S Karan; Tatyana A Shopenskaya; Olga V Platonova; Vitaly I Zhuravlev
Journal:  Parasitol Res       Date:  2008-11-23       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.